The success of Sildenafil initially fueled a period of growth for major pharmaceutical companies, but recent shifts present a murky outlook for those considering a stake. Generic versions are eating into earnings, and https://theresavpui994558.blogofoto.com/72620071/viagra-and-the-pharmaceutical-industry-a-risky-investment